Genetic variation in human drug-related genes
Abstract Background Variability in drug efficacy and adverse effects are observed in clinical practice. While the extent of genetic variability in classic pharmacokinetic genes is rather well understood, the role of genetic variation in drug targets is typically less studied. Methods Based on 60,706...
Hoofdauteurs: | Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
BMC
2017-12-01
|
Reeks: | Genome Medicine |
Onderwerpen: | |
Online toegang: | http://link.springer.com/article/10.1186/s13073-017-0502-5 |
Gelijkaardige items
-
A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort
door: Kathrin Klein, et al.
Gepubliceerd in: (2019-01-01) -
Pharmacogenomics-Based Detection of Variants Involved in Pain, Anti-inflammatory and Immunomodulating Agents Pathways by Whole Exome Sequencing and Deep in Silico Investigations Revealed Novel Chemical Carcinogenesis and Cancer Risks
door: Alireza Sharafshah, et al.
Gepubliceerd in: (2025-02-01) -
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing
door: Daniel Felipe Silgado-Guzmán, et al.
Gepubliceerd in: (2022-06-01) -
PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
door: N. V. Shcherbakova, et al.
Gepubliceerd in: (2015-09-01) -
Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
door: Abdeslam Jaafari, et al.
Gepubliceerd in: (2022-11-01)